ATE549348T1 - Therapeutische, sich von uspa1 ableitende peptide - Google Patents
Therapeutische, sich von uspa1 ableitende peptideInfo
- Publication number
- ATE549348T1 ATE549348T1 AT03756554T AT03756554T ATE549348T1 AT E549348 T1 ATE549348 T1 AT E549348T1 AT 03756554 T AT03756554 T AT 03756554T AT 03756554 T AT03756554 T AT 03756554T AT E549348 T1 ATE549348 T1 AT E549348T1
- Authority
- AT
- Austria
- Prior art keywords
- ligand
- uspa1
- peptides derived
- therapeutic peptides
- provides
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 241000588655 Moraxella catarrhalis Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222764.3A GB0222764D0 (en) | 2002-10-02 | 2002-10-02 | Therapeutic peptide |
| PCT/GB2003/004273 WO2004031236A2 (en) | 2002-10-02 | 2003-10-01 | Therapeutic uspa1-derived peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE549348T1 true ATE549348T1 (de) | 2012-03-15 |
Family
ID=9945111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03756554T ATE549348T1 (de) | 2002-10-02 | 2003-10-01 | Therapeutische, sich von uspa1 ableitende peptide |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP2305700A1 (de) |
| JP (1) | JP4763291B2 (de) |
| KR (1) | KR101057587B1 (de) |
| CN (1) | CN1305899C (de) |
| AT (1) | ATE549348T1 (de) |
| AU (1) | AU2003299131B2 (de) |
| BR (1) | BR0315031A (de) |
| CA (1) | CA2500960A1 (de) |
| ES (1) | ES2383958T3 (de) |
| GB (1) | GB0222764D0 (de) |
| IL (1) | IL167780A (de) |
| MX (1) | MXPA05003474A (de) |
| NO (1) | NO20052108L (de) |
| NZ (1) | NZ539575A (de) |
| PL (1) | PL376052A1 (de) |
| WO (1) | WO2004031236A2 (de) |
| ZA (1) | ZA200503446B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1735446A2 (de) * | 2004-04-15 | 2006-12-27 | University Of Bristol | Therapeutische peptide |
| EA014352B1 (ru) | 2005-08-10 | 2010-10-29 | Арне Форсгрен Аб | Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента |
| TW201302779A (zh) | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0948625B1 (de) * | 1996-12-20 | 2011-01-26 | The Board Of Regents, The University Of Texas System | Moraxella catarrhalis antigene uspa1 und uspa2 |
-
2002
- 2002-10-02 GB GBGB0222764.3A patent/GB0222764D0/en not_active Ceased
-
2003
- 2003-10-01 WO PCT/GB2003/004273 patent/WO2004031236A2/en not_active Ceased
- 2003-10-01 AU AU2003299131A patent/AU2003299131B2/en not_active Ceased
- 2003-10-01 EP EP10177682A patent/EP2305700A1/de not_active Withdrawn
- 2003-10-01 KR KR1020057005764A patent/KR101057587B1/ko not_active Expired - Fee Related
- 2003-10-01 JP JP2004540969A patent/JP4763291B2/ja not_active Expired - Fee Related
- 2003-10-01 CA CA002500960A patent/CA2500960A1/en not_active Abandoned
- 2003-10-01 PL PL03376052A patent/PL376052A1/xx not_active IP Right Cessation
- 2003-10-01 MX MXPA05003474A patent/MXPA05003474A/es active IP Right Grant
- 2003-10-01 EP EP03756554A patent/EP1546194B1/de not_active Expired - Lifetime
- 2003-10-01 AT AT03756554T patent/ATE549348T1/de active
- 2003-10-01 CN CNB2003801017669A patent/CN1305899C/zh not_active Expired - Fee Related
- 2003-10-01 NZ NZ539575A patent/NZ539575A/en not_active IP Right Cessation
- 2003-10-01 ES ES03756554T patent/ES2383958T3/es not_active Expired - Lifetime
- 2003-10-01 BR BR0315031-3A patent/BR0315031A/pt not_active IP Right Cessation
-
2005
- 2005-03-31 IL IL167780A patent/IL167780A/en not_active IP Right Cessation
- 2005-04-29 ZA ZA200503446A patent/ZA200503446B/en unknown
- 2005-04-29 NO NO20052108A patent/NO20052108L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1076475A1 (en) | 2006-01-20 |
| CN1705678A (zh) | 2005-12-07 |
| CN1305899C (zh) | 2007-03-21 |
| EP2305700A1 (de) | 2011-04-06 |
| AU2003299131B2 (en) | 2010-04-22 |
| IL167780A (en) | 2011-05-31 |
| AU2003299131A1 (en) | 2004-04-23 |
| EP1546194A2 (de) | 2005-06-29 |
| NZ539575A (en) | 2006-06-30 |
| KR101057587B1 (ko) | 2011-08-19 |
| WO2004031236A2 (en) | 2004-04-15 |
| BR0315031A (pt) | 2005-08-16 |
| NO20052108L (no) | 2005-06-27 |
| ES2383958T3 (es) | 2012-06-27 |
| PL376052A1 (en) | 2005-12-12 |
| MXPA05003474A (es) | 2005-10-18 |
| JP2006516952A (ja) | 2006-07-13 |
| CA2500960A1 (en) | 2004-04-15 |
| GB0222764D0 (en) | 2002-11-06 |
| JP4763291B2 (ja) | 2011-08-31 |
| ZA200503446B (en) | 2006-10-25 |
| EP1546194B1 (de) | 2012-03-14 |
| KR20050067410A (ko) | 2005-07-01 |
| WO2004031236A3 (en) | 2004-06-24 |
| NO20052108D0 (no) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69638022D1 (de) | Aus wirbeltieren und darauf basierende verfahren | |
| DK0861261T3 (da) | Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå | |
| SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
| UA103154C2 (uk) | Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його | |
| EP1539228A4 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
| NO20045021L (no) | Immunologiske metoder og preparater for behandling av Alzheimers sykdom | |
| AU2003270643A1 (en) | Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence | |
| BR0010720A (pt) | Peptìdeos de neisseria antigênicos | |
| NL300830I2 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
| ATE132197T1 (de) | Monoklonale antikörper | |
| PT996726E (pt) | Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes | |
| DK0494294T3 (da) | Bakterielle stressproteiner | |
| Sletten et al. | The primary structure of equine serum amyloid A (SAA) protein | |
| ATE549348T1 (de) | Therapeutische, sich von uspa1 ableitende peptide | |
| WO2005099337A3 (en) | Therapeutic peptides | |
| Rajnavölgyi et al. | Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites | |
| Schade et al. | Livetin fractions (IgY) | |
| SE0102410D0 (sv) | Novel surface exposed immunoglobulin D-binding protein from moraxella catarrhalis | |
| ATE411812T1 (de) | Peptide zur behandlung von infektionen mit dem herpes-virus | |
| JPH06100591A (ja) | ペプチド、それらから誘導される抗体並びにその抗体を含有する抗ニュ−カッスル病薬 | |
| Conde et al. | Comparative studies of sheep immunoglobulins IgG1 and IgG2: Amino acid sequence of carboxy‐terminal cyanogen bromide fragments from their heavy chains | |
| WO2003064446A3 (en) | Plasma protein-binding peptides from bacterial curli | |
| EP1467207A4 (de) | Screening-verfahren | |
| WO2007030771A4 (en) | Targeted identification of immunogenic peptides | |
| ATE465175T1 (de) | Neuer proteinkomplex und anwendungen davon |